A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

Clinical trial NCT05864144 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05864144
Sponsor: Sensei Biotherapeutics, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor, Adult Advanced Solid Tumor Head and Neck Cancer Breast Cancer Colon Cancer Pancreatic Cancer Gastric Cancer Esophageal Cancer Prostate Cancer Uterine Cancer Cervix Cancer Ovarian Cancer

Start date: 2023-05-31
Primary completion: 2027-06-01
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.